| abstract |
THE INVENTION CONCERNS COMPOUNDS OF GENERAL FORMULA I WHERE SUBSTITUTES ARE DEFINED IN THE CLAIM 1. THESE COMPOUNDS HAVE A GOOD AFFINITY TO THE SELECTIVE BLOCKERS OF A NMDA RECEIVER SUBTIPE (N-METHYL-D-ASPARTAT), WHICH IT HAS A KEY FUNCTION IN THE MODULATION OF NEURONAL ACTIVITY AND PLASTICITY THAT MAKES IT DEVELOP A KEY ROLE IN THE MEDIATION OF UNDERLYING PROCESSES TO THE DEVELOPMENT OF THE SNC BOTH AS THE LEARNING AND THE FORMATION OF THE MEMORY. THESE COMPOUNDS ARE THEREFORE ADEQUATE IN THE CONTROL OR TREATMENT OF DISEASES, RELATED TO THIS RECEIVER. |